MedTrace Logo

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

NCT06902285 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-04-23

No results posted yet for this study

Summary

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery

Conditions

Interventions

DRUG

Magnesium Threonate

Participants will receive a daily 145 mg pill by mouth 30 minutes before going to sleep

OTHER

Control

Participants will receive two sugar pills daily by mouth 30 minutes before going to sleep

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Victor H Hernandez, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-21
Primary Completion
2026-07-01
Completion
2026-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06902285 on ClinicalTrials.gov